Avance Medical

SICOT Orthopaedic World Congress Cape Town; Perioperative prepared autologous cartilage scaffold in osteochondral lesions

^h SICOT Orthopaedic World Congress 2017 Cape Town; South Africa

As invited speaker dr Abazović, Avance Medical's principal clinical investigator, presented novel techniques in orthopaedic treatment through lecture “Perioperative prepared autologous cartilage scaffold in osteochondral lesions” utilizing Avance Medical's patented bio-regenerative fibrin (TM) technology platform. The lecture was very noticeable since the autologous components and their usage were presented through fantastic results obtained through the completely autologous treatment of patient with osteochondral lesions.

ESTROT 2017: Immunophenotypisation and cell quantity in bone marrow aspirate concentrate harvested from proximal tibia

3^rd ESTROT Congress 2017 Leeds; United Kingdom

Through the lecture “Immunophenotypisation and cell quantity in bone marrow aspirate concentrate harvested from proximal tibia” dr Abazović, Avance Medical's principal clinical investigator, presented results of Mesenchymal Stem Cells immunophenotypisation and underlined the tibia presents valuable source of stem cells to be seeded in bio-regenerative fibrin (TM) scaffold.

ICRS: Stem Cells and Bio-regenerative Autologous scaffold in Ankle chondral lesions

13^th World Congress ICRS 2016 Sorrento; Italy

On one of the greatest orthopaedic congresses dr Abazović, Avance Medical's principal clinical consultant, held a lecture ”Stem Cells and Bio-regenerative Autologous scaffold in Ankle chondral lesions”. The presented technique and components implemented in the procedures annunciated autologous components era and importance of their usage in different fields of medicine.

Utilizing Avance Medical's patented technique to produce autologous fibrin scaffold for seeding of mesenchymal stem cells and placement in chondral lesions showing excellent results compared to conventional techniques

Avance accepted for poster presentation at ESCVS

We are pleased to announce that our trial has also been accepted for a poster presentation at the upcoming 65th International Congress of the European Society for CardioVascular and Endovascular Surgery titled: „Application Of Autologous Bio-regenerative Fibrin Sealant In Elective Coronary Artery Bypass Surgery Improves Post-operative Hemostasis And Lowers The Rate Of Allogeneic Blood Transfusions“

Abstract accepted 25th Congress of the World Society of Cardio-Thoracic Surgeons 2015

Avance is pleased to announce the acceptance of an abstract on reducing donor blood transfusions in cardiac surgery at the 25th World Congress of the World Society of Cardio-Thoracic Surgeons 2015 in Edinburgh Scotland 19 - 22nd September 2015 http://www.wscts2015.org/